Viatris files 8-K for merger agreement with Pacira BioSciences
Viatris Inc. has filed an 8-K with the SEC announcing a merger agreement with Pacira BioSciences. The deal could reshape the pharmaceutical landscape.
Venture Global files 8-K on arbitration ruling with Galp
Venture Global, Inc. filed an 8-K detailing an arbitration ruling related to LNG sales. The decision may impact future agreements and operations.
Virginia National Bankshares announces $18.7M stock buyback
Virginia National Bankshares Corp has filed an 8-K to announce a share repurchase plan authorizing up to $18.7 million in stock buybacks through 2027.
Editas Medicine Files 8-K for Clinical Trial Approval
Editas Medicine, Inc. filed an 8-K revealing approval for a clinical trial of EDIT-401, a gene editing treatment for hyperlipidemia, on October 8, 2026.
AngioDynamics appoints new CEO, Eric Honroth, in SEC filing
AngioDynamics Inc. filed an 8-K with the SEC announcing Eric Honroth as the new CEO, succeeding James Clemmer, who will retire soon.
New ERA Energy files 8-K detailing financial agreements
New ERA Energy & Digital, Inc. filed an 8-K with the SEC, revealing a $116 million letter of credit agreement and other financial obligations.
NexGel Inc. Files 8-K for Reverse Stock Split Approval
NexGel Inc. has filed an 8-K with the SEC detailing a reverse stock split approved by shareholders, set to take effect on October 12, 2026.
Scienture Holdings files 8-K detailing reverse stock split
Scienture Holdings, Inc. announces a 1-for-25 reverse stock split in an effort to comply with Nasdaq listing rules, as detailed in their recent SEC filing.
MSD Investment Corp. Prices $350 Million Note Offering
MSD Investment Corp. filed an 8-K detailing a $350 million note offering to repay debt and fund corporate purposes, as per SEC regulations.
CNL Strategic Capital reports $29.2 million equity sale
CNL Strategic Capital, LLC filed an 8-K detailing a $29.2 million equity sale from its subsidiary, impacting stakeholders and future investments.
Lululemon Announces Leadership Changes in Recent SEC Filing
Lululemon athletica Inc. files an 8-K detailing leadership changes, including new appointments and departures of key executives, effective October 2026.
Columbus Acquisition Corp Completes Business Combination
Columbus Acquisition Corp has finalized its merger with WISeSat.Space Holdings, affecting its stock and trading status on Nasdaq.
Rivian Secures $1 Billion Loan from Volkswagen Group
Rivian Automotive filed an 8-K revealing a $1 billion loan from Volkswagen to support its joint venture. This funding could impact Rivian's operations and growth.
T3 Defense Inc. Appoints New Chief Financial Officer
T3 Defense Inc. has appointed Shlomo Zakai as its new Chief Financial Officer, effective October 5, 2026, according to a recent SEC filing.
FatPipe Inc. Secures $6 Million in New Financing
FatPipe Inc. has filed an 8-K detailing a $6 million financing agreement with KeyBank, aimed at refinancing existing debt and improving cash flow.
Tessera Defense files 8-K on executive appointments and pay
Tessera Defense & Homeland Security Inc. files an 8-K detailing new compensation agreements for its CEO and CFO, impacting stockholder interests.
BANK5 2026-5YR24 Files 8-K with SEC on October 7, 2026
BANK5 2026-5YR24 submitted an 8-K filing detailing a new material agreement involving commercial mortgage pass-through certificates.
VIP Play, Inc. Files 8-K on Convertible Note Amendments
VIP Play, Inc. filed an 8-K detailing amendments to convertible notes, extending maturity dates and altering agreement terms, impacting investors.
Modine Manufacturing files amended 8-K following spin-off
Modine Manufacturing Co. has filed an amended 8-K to provide pro forma financial information after its recent spin-off of the Performance Technologies business.
Charlton Aria Acquisition Corp Files 8-K for Business Deal
Charlton Aria Acquisition Corp filed an 8-K with the SEC detailing a business combination with KQC Quantum, Inc. Read more about the implications.